Global Filgotinib Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Filgotinib market size was valued at US$ million in 2023. With growing demand in downstream market, the Filgotinib is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Filgotinib market. Filgotinib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Filgotinib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Filgotinib market.
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Key Features:
The report on Filgotinib market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Filgotinib market. It may include historical data, market segmentation by Type (e.g., Min Purity Less Than 98%, Min Purity 98%-99%), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Filgotinib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Filgotinib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Filgotinib industry. This include advancements in Filgotinib technology, Filgotinib new entrants, Filgotinib new investment, and other innovations that are shaping the future of Filgotinib.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Filgotinib market. It includes factors influencing customer ' purchasing decisions, preferences for Filgotinib product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Filgotinib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Filgotinib market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Filgotinib market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Filgotinib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Filgotinib market.
Market Segmentation:
Filgotinib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Filgotinib market?
What factors are driving Filgotinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Filgotinib market opportunities vary by end market size?
How does Filgotinib break out type, application?
According to our LPI (LP Information) latest study, the global Filgotinib market size was valued at US$ million in 2023. With growing demand in downstream market, the Filgotinib is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Filgotinib market. Filgotinib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Filgotinib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Filgotinib market.
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Key Features:
The report on Filgotinib market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Filgotinib market. It may include historical data, market segmentation by Type (e.g., Min Purity Less Than 98%, Min Purity 98%-99%), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Filgotinib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Filgotinib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Filgotinib industry. This include advancements in Filgotinib technology, Filgotinib new entrants, Filgotinib new investment, and other innovations that are shaping the future of Filgotinib.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Filgotinib market. It includes factors influencing customer ' purchasing decisions, preferences for Filgotinib product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Filgotinib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Filgotinib market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Filgotinib market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Filgotinib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Filgotinib market.
Market Segmentation:
Filgotinib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- Research
- Medical
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cayman Chemical
- BioVision
- Adooq Bioscience
- Taiclone
- Clearsynth
- Biorbyt
- APExBIO Technology
- Selleck Chemicals
- AbMole
- BOC Sciences
- TargetMol
- Toronto Research Chemicals
- J&K Scientific
What is the 10-year outlook for the global Filgotinib market?
What factors are driving Filgotinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Filgotinib market opportunities vary by end market size?
How does Filgotinib break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Filgotinib Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Filgotinib by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Filgotinib by Country/Region, 2019, 2023 & 2030
2.2 Filgotinib Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Filgotinib Sales by Type
2.3.1 Global Filgotinib Sales Market Share by Type (2019-2024)
2.3.2 Global Filgotinib Revenue and Market Share by Type (2019-2024)
2.3.3 Global Filgotinib Sale Price by Type (2019-2024)
2.4 Filgotinib Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Filgotinib Sales by Application
2.5.1 Global Filgotinib Sale Market Share by Application (2019-2024)
2.5.2 Global Filgotinib Revenue and Market Share by Application (2019-2024)
2.5.3 Global Filgotinib Sale Price by Application (2019-2024)
3 GLOBAL FILGOTINIB BY COMPANY
3.1 Global Filgotinib Breakdown Data by Company
3.1.1 Global Filgotinib Annual Sales by Company (2019-2024)
3.1.2 Global Filgotinib Sales Market Share by Company (2019-2024)
3.2 Global Filgotinib Annual Revenue by Company (2019-2024)
3.2.1 Global Filgotinib Revenue by Company (2019-2024)
3.2.2 Global Filgotinib Revenue Market Share by Company (2019-2024)
3.3 Global Filgotinib Sale Price by Company
3.4 Key Manufacturers Filgotinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Filgotinib Product Location Distribution
3.4.2 Players Filgotinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FILGOTINIB BY GEOGRAPHIC REGION
4.1 World Historic Filgotinib Market Size by Geographic Region (2019-2024)
4.1.1 Global Filgotinib Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Filgotinib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Filgotinib Market Size by Country/Region (2019-2024)
4.2.1 Global Filgotinib Annual Sales by Country/Region (2019-2024)
4.2.2 Global Filgotinib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Filgotinib Sales Growth
4.4 APAC Filgotinib Sales Growth
4.5 Europe Filgotinib Sales Growth
4.6 Middle East & Africa Filgotinib Sales Growth
5 AMERICAS
5.1 Americas Filgotinib Sales by Country
5.1.1 Americas Filgotinib Sales by Country (2019-2024)
5.1.2 Americas Filgotinib Revenue by Country (2019-2024)
5.2 Americas Filgotinib Sales by Type
5.3 Americas Filgotinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Filgotinib Sales by Region
6.1.1 APAC Filgotinib Sales by Region (2019-2024)
6.1.2 APAC Filgotinib Revenue by Region (2019-2024)
6.2 APAC Filgotinib Sales by Type
6.3 APAC Filgotinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Filgotinib by Country
7.1.1 Europe Filgotinib Sales by Country (2019-2024)
7.1.2 Europe Filgotinib Revenue by Country (2019-2024)
7.2 Europe Filgotinib Sales by Type
7.3 Europe Filgotinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Filgotinib by Country
8.1.1 Middle East & Africa Filgotinib Sales by Country (2019-2024)
8.1.2 Middle East & Africa Filgotinib Revenue by Country (2019-2024)
8.2 Middle East & Africa Filgotinib Sales by Type
8.3 Middle East & Africa Filgotinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Filgotinib
10.3 Manufacturing Process Analysis of Filgotinib
10.4 Industry Chain Structure of Filgotinib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Filgotinib Distributors
11.3 Filgotinib Customer
12 WORLD FORECAST REVIEW FOR FILGOTINIB BY GEOGRAPHIC REGION
12.1 Global Filgotinib Market Size Forecast by Region
12.1.1 Global Filgotinib Forecast by Region (2025-2030)
12.1.2 Global Filgotinib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Filgotinib Forecast by Type
12.7 Global Filgotinib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Cayman Chemical
13.1.1 Cayman Chemical Company Information
13.1.2 Cayman Chemical Filgotinib Product Portfolios and Specifications
13.1.3 Cayman Chemical Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Cayman Chemical Main Business Overview
13.1.5 Cayman Chemical Latest Developments
13.2 BioVision
13.2.1 BioVision Company Information
13.2.2 BioVision Filgotinib Product Portfolios and Specifications
13.2.3 BioVision Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BioVision Main Business Overview
13.2.5 BioVision Latest Developments
13.3 Adooq Bioscience
13.3.1 Adooq Bioscience Company Information
13.3.2 Adooq Bioscience Filgotinib Product Portfolios and Specifications
13.3.3 Adooq Bioscience Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Adooq Bioscience Main Business Overview
13.3.5 Adooq Bioscience Latest Developments
13.4 Taiclone
13.4.1 Taiclone Company Information
13.4.2 Taiclone Filgotinib Product Portfolios and Specifications
13.4.3 Taiclone Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Taiclone Main Business Overview
13.4.5 Taiclone Latest Developments
13.5 Clearsynth
13.5.1 Clearsynth Company Information
13.5.2 Clearsynth Filgotinib Product Portfolios and Specifications
13.5.3 Clearsynth Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Clearsynth Main Business Overview
13.5.5 Clearsynth Latest Developments
13.6 Biorbyt
13.6.1 Biorbyt Company Information
13.6.2 Biorbyt Filgotinib Product Portfolios and Specifications
13.6.3 Biorbyt Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Biorbyt Main Business Overview
13.6.5 Biorbyt Latest Developments
13.7 APExBIO Technology
13.7.1 APExBIO Technology Company Information
13.7.2 APExBIO Technology Filgotinib Product Portfolios and Specifications
13.7.3 APExBIO Technology Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 APExBIO Technology Main Business Overview
13.7.5 APExBIO Technology Latest Developments
13.8 Selleck Chemicals
13.8.1 Selleck Chemicals Company Information
13.8.2 Selleck Chemicals Filgotinib Product Portfolios and Specifications
13.8.3 Selleck Chemicals Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Selleck Chemicals Main Business Overview
13.8.5 Selleck Chemicals Latest Developments
13.9 AbMole
13.9.1 AbMole Company Information
13.9.2 AbMole Filgotinib Product Portfolios and Specifications
13.9.3 AbMole Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AbMole Main Business Overview
13.9.5 AbMole Latest Developments
13.10 BOC Sciences
13.10.1 BOC Sciences Company Information
13.10.2 BOC Sciences Filgotinib Product Portfolios and Specifications
13.10.3 BOC Sciences Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BOC Sciences Main Business Overview
13.10.5 BOC Sciences Latest Developments
13.11 TargetMol
13.11.1 TargetMol Company Information
13.11.2 TargetMol Filgotinib Product Portfolios and Specifications
13.11.3 TargetMol Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 TargetMol Main Business Overview
13.11.5 TargetMol Latest Developments
13.12 Toronto Research Chemicals
13.12.1 Toronto Research Chemicals Company Information
13.12.2 Toronto Research Chemicals Filgotinib Product Portfolios and Specifications
13.12.3 Toronto Research Chemicals Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Toronto Research Chemicals Main Business Overview
13.12.5 Toronto Research Chemicals Latest Developments
13.13 J&K Scientific
13.13.1 J&K Scientific Company Information
13.13.2 J&K Scientific Filgotinib Product Portfolios and Specifications
13.13.3 J&K Scientific Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 J&K Scientific Main Business Overview
13.13.5 J&K Scientific Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Filgotinib Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Filgotinib by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Filgotinib by Country/Region, 2019, 2023 & 2030
2.2 Filgotinib Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Filgotinib Sales by Type
2.3.1 Global Filgotinib Sales Market Share by Type (2019-2024)
2.3.2 Global Filgotinib Revenue and Market Share by Type (2019-2024)
2.3.3 Global Filgotinib Sale Price by Type (2019-2024)
2.4 Filgotinib Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Filgotinib Sales by Application
2.5.1 Global Filgotinib Sale Market Share by Application (2019-2024)
2.5.2 Global Filgotinib Revenue and Market Share by Application (2019-2024)
2.5.3 Global Filgotinib Sale Price by Application (2019-2024)
3 GLOBAL FILGOTINIB BY COMPANY
3.1 Global Filgotinib Breakdown Data by Company
3.1.1 Global Filgotinib Annual Sales by Company (2019-2024)
3.1.2 Global Filgotinib Sales Market Share by Company (2019-2024)
3.2 Global Filgotinib Annual Revenue by Company (2019-2024)
3.2.1 Global Filgotinib Revenue by Company (2019-2024)
3.2.2 Global Filgotinib Revenue Market Share by Company (2019-2024)
3.3 Global Filgotinib Sale Price by Company
3.4 Key Manufacturers Filgotinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Filgotinib Product Location Distribution
3.4.2 Players Filgotinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FILGOTINIB BY GEOGRAPHIC REGION
4.1 World Historic Filgotinib Market Size by Geographic Region (2019-2024)
4.1.1 Global Filgotinib Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Filgotinib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Filgotinib Market Size by Country/Region (2019-2024)
4.2.1 Global Filgotinib Annual Sales by Country/Region (2019-2024)
4.2.2 Global Filgotinib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Filgotinib Sales Growth
4.4 APAC Filgotinib Sales Growth
4.5 Europe Filgotinib Sales Growth
4.6 Middle East & Africa Filgotinib Sales Growth
5 AMERICAS
5.1 Americas Filgotinib Sales by Country
5.1.1 Americas Filgotinib Sales by Country (2019-2024)
5.1.2 Americas Filgotinib Revenue by Country (2019-2024)
5.2 Americas Filgotinib Sales by Type
5.3 Americas Filgotinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Filgotinib Sales by Region
6.1.1 APAC Filgotinib Sales by Region (2019-2024)
6.1.2 APAC Filgotinib Revenue by Region (2019-2024)
6.2 APAC Filgotinib Sales by Type
6.3 APAC Filgotinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Filgotinib by Country
7.1.1 Europe Filgotinib Sales by Country (2019-2024)
7.1.2 Europe Filgotinib Revenue by Country (2019-2024)
7.2 Europe Filgotinib Sales by Type
7.3 Europe Filgotinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Filgotinib by Country
8.1.1 Middle East & Africa Filgotinib Sales by Country (2019-2024)
8.1.2 Middle East & Africa Filgotinib Revenue by Country (2019-2024)
8.2 Middle East & Africa Filgotinib Sales by Type
8.3 Middle East & Africa Filgotinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Filgotinib
10.3 Manufacturing Process Analysis of Filgotinib
10.4 Industry Chain Structure of Filgotinib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Filgotinib Distributors
11.3 Filgotinib Customer
12 WORLD FORECAST REVIEW FOR FILGOTINIB BY GEOGRAPHIC REGION
12.1 Global Filgotinib Market Size Forecast by Region
12.1.1 Global Filgotinib Forecast by Region (2025-2030)
12.1.2 Global Filgotinib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Filgotinib Forecast by Type
12.7 Global Filgotinib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Cayman Chemical
13.1.1 Cayman Chemical Company Information
13.1.2 Cayman Chemical Filgotinib Product Portfolios and Specifications
13.1.3 Cayman Chemical Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Cayman Chemical Main Business Overview
13.1.5 Cayman Chemical Latest Developments
13.2 BioVision
13.2.1 BioVision Company Information
13.2.2 BioVision Filgotinib Product Portfolios and Specifications
13.2.3 BioVision Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BioVision Main Business Overview
13.2.5 BioVision Latest Developments
13.3 Adooq Bioscience
13.3.1 Adooq Bioscience Company Information
13.3.2 Adooq Bioscience Filgotinib Product Portfolios and Specifications
13.3.3 Adooq Bioscience Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Adooq Bioscience Main Business Overview
13.3.5 Adooq Bioscience Latest Developments
13.4 Taiclone
13.4.1 Taiclone Company Information
13.4.2 Taiclone Filgotinib Product Portfolios and Specifications
13.4.3 Taiclone Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Taiclone Main Business Overview
13.4.5 Taiclone Latest Developments
13.5 Clearsynth
13.5.1 Clearsynth Company Information
13.5.2 Clearsynth Filgotinib Product Portfolios and Specifications
13.5.3 Clearsynth Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Clearsynth Main Business Overview
13.5.5 Clearsynth Latest Developments
13.6 Biorbyt
13.6.1 Biorbyt Company Information
13.6.2 Biorbyt Filgotinib Product Portfolios and Specifications
13.6.3 Biorbyt Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Biorbyt Main Business Overview
13.6.5 Biorbyt Latest Developments
13.7 APExBIO Technology
13.7.1 APExBIO Technology Company Information
13.7.2 APExBIO Technology Filgotinib Product Portfolios and Specifications
13.7.3 APExBIO Technology Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 APExBIO Technology Main Business Overview
13.7.5 APExBIO Technology Latest Developments
13.8 Selleck Chemicals
13.8.1 Selleck Chemicals Company Information
13.8.2 Selleck Chemicals Filgotinib Product Portfolios and Specifications
13.8.3 Selleck Chemicals Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Selleck Chemicals Main Business Overview
13.8.5 Selleck Chemicals Latest Developments
13.9 AbMole
13.9.1 AbMole Company Information
13.9.2 AbMole Filgotinib Product Portfolios and Specifications
13.9.3 AbMole Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AbMole Main Business Overview
13.9.5 AbMole Latest Developments
13.10 BOC Sciences
13.10.1 BOC Sciences Company Information
13.10.2 BOC Sciences Filgotinib Product Portfolios and Specifications
13.10.3 BOC Sciences Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BOC Sciences Main Business Overview
13.10.5 BOC Sciences Latest Developments
13.11 TargetMol
13.11.1 TargetMol Company Information
13.11.2 TargetMol Filgotinib Product Portfolios and Specifications
13.11.3 TargetMol Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 TargetMol Main Business Overview
13.11.5 TargetMol Latest Developments
13.12 Toronto Research Chemicals
13.12.1 Toronto Research Chemicals Company Information
13.12.2 Toronto Research Chemicals Filgotinib Product Portfolios and Specifications
13.12.3 Toronto Research Chemicals Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Toronto Research Chemicals Main Business Overview
13.12.5 Toronto Research Chemicals Latest Developments
13.13 J&K Scientific
13.13.1 J&K Scientific Company Information
13.13.2 J&K Scientific Filgotinib Product Portfolios and Specifications
13.13.3 J&K Scientific Filgotinib Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 J&K Scientific Main Business Overview
13.13.5 J&K Scientific Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Filgotinib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Filgotinib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Filgotinib Sales by Type (2019-2024) & (Kg)
Table 7. Global Filgotinib Sales Market Share by Type (2019-2024)
Table 8. Global Filgotinib Revenue by Type (2019-2024) & ($ million)
Table 9. Global Filgotinib Revenue Market Share by Type (2019-2024)
Table 10. Global Filgotinib Sale Price by Type (2019-2024) & (K USD/Kg)
Table 11. Global Filgotinib Sales by Application (2019-2024) & (Kg)
Table 12. Global Filgotinib Sales Market Share by Application (2019-2024)
Table 13. Global Filgotinib Revenue by Application (2019-2024)
Table 14. Global Filgotinib Revenue Market Share by Application (2019-2024)
Table 15. Global Filgotinib Sale Price by Application (2019-2024) & (K USD/Kg)
Table 16. Global Filgotinib Sales by Company (2019-2024) & (Kg)
Table 17. Global Filgotinib Sales Market Share by Company (2019-2024)
Table 18. Global Filgotinib Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Filgotinib Revenue Market Share by Company (2019-2024)
Table 20. Global Filgotinib Sale Price by Company (2019-2024) & (K USD/Kg)
Table 21. Key Manufacturers Filgotinib Producing Area Distribution and Sales Area
Table 22. Players Filgotinib Products Offered
Table 23. Filgotinib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Filgotinib Sales by Geographic Region (2019-2024) & (Kg)
Table 27. Global Filgotinib Sales Market Share Geographic Region (2019-2024)
Table 28. Global Filgotinib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Filgotinib Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Filgotinib Sales by Country/Region (2019-2024) & (Kg)
Table 31. Global Filgotinib Sales Market Share by Country/Region (2019-2024)
Table 32. Global Filgotinib Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Filgotinib Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Filgotinib Sales by Country (2019-2024) & (Kg)
Table 35. Americas Filgotinib Sales Market Share by Country (2019-2024)
Table 36. Americas Filgotinib Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Filgotinib Revenue Market Share by Country (2019-2024)
Table 38. Americas Filgotinib Sales by Type (2019-2024) & (Kg)
Table 39. Americas Filgotinib Sales by Application (2019-2024) & (Kg)
Table 40. APAC Filgotinib Sales by Region (2019-2024) & (Kg)
Table 41. APAC Filgotinib Sales Market Share by Region (2019-2024)
Table 42. APAC Filgotinib Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Filgotinib Revenue Market Share by Region (2019-2024)
Table 44. APAC Filgotinib Sales by Type (2019-2024) & (Kg)
Table 45. APAC Filgotinib Sales by Application (2019-2024) & (Kg)
Table 46. Europe Filgotinib Sales by Country (2019-2024) & (Kg)
Table 47. Europe Filgotinib Sales Market Share by Country (2019-2024)
Table 48. Europe Filgotinib Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Filgotinib Revenue Market Share by Country (2019-2024)
Table 50. Europe Filgotinib Sales by Type (2019-2024) & (Kg)
Table 51. Europe Filgotinib Sales by Application (2019-2024) & (Kg)
Table 52. Middle East & Africa Filgotinib Sales by Country (2019-2024) & (Kg)
Table 53. Middle East & Africa Filgotinib Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Filgotinib Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Filgotinib Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Filgotinib Sales by Type (2019-2024) & (Kg)
Table 57. Middle East & Africa Filgotinib Sales by Application (2019-2024) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Filgotinib
Table 59. Key Market Challenges & Risks of Filgotinib
Table 60. Key Industry Trends of Filgotinib
Table 61. Filgotinib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Filgotinib Distributors List
Table 64. Filgotinib Customer List
Table 65. Global Filgotinib Sales Forecast by Region (2025-2030) & (Kg)
Table 66. Global Filgotinib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Filgotinib Sales Forecast by Country (2025-2030) & (Kg)
Table 68. Americas Filgotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Filgotinib Sales Forecast by Region (2025-2030) & (Kg)
Table 70. APAC Filgotinib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Filgotinib Sales Forecast by Country (2025-2030) & (Kg)
Table 72. Europe Filgotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Filgotinib Sales Forecast by Country (2025-2030) & (Kg)
Table 74. Middle East & Africa Filgotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Filgotinib Sales Forecast by Type (2025-2030) & (Kg)
Table 76. Global Filgotinib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Filgotinib Sales Forecast by Application (2025-2030) & (Kg)
Table 78. Global Filgotinib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Cayman Chemical Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 80. Cayman Chemical Filgotinib Product Portfolios and Specifications
Table 81. Cayman Chemical Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 82. Cayman Chemical Main Business
Table 83. Cayman Chemical Latest Developments
Table 84. BioVision Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 85. BioVision Filgotinib Product Portfolios and Specifications
Table 86. BioVision Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 87. BioVision Main Business
Table 88. BioVision Latest Developments
Table 89. Adooq Bioscience Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 90. Adooq Bioscience Filgotinib Product Portfolios and Specifications
Table 91. Adooq Bioscience Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 92. Adooq Bioscience Main Business
Table 93. Adooq Bioscience Latest Developments
Table 94. Taiclone Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 95. Taiclone Filgotinib Product Portfolios and Specifications
Table 96. Taiclone Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 97. Taiclone Main Business
Table 98. Taiclone Latest Developments
Table 99. Clearsynth Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 100. Clearsynth Filgotinib Product Portfolios and Specifications
Table 101. Clearsynth Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 102. Clearsynth Main Business
Table 103. Clearsynth Latest Developments
Table 104. Biorbyt Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 105. Biorbyt Filgotinib Product Portfolios and Specifications
Table 106. Biorbyt Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 107. Biorbyt Main Business
Table 108. Biorbyt Latest Developments
Table 109. APExBIO Technology Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 110. APExBIO Technology Filgotinib Product Portfolios and Specifications
Table 111. APExBIO Technology Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 112. APExBIO Technology Main Business
Table 113. APExBIO Technology Latest Developments
Table 114. Selleck Chemicals Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 115. Selleck Chemicals Filgotinib Product Portfolios and Specifications
Table 116. Selleck Chemicals Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 117. Selleck Chemicals Main Business
Table 118. Selleck Chemicals Latest Developments
Table 119. AbMole Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 120. AbMole Filgotinib Product Portfolios and Specifications
Table 121. AbMole Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 122. AbMole Main Business
Table 123. AbMole Latest Developments
Table 124. BOC Sciences Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 125. BOC Sciences Filgotinib Product Portfolios and Specifications
Table 126. BOC Sciences Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 127. BOC Sciences Main Business
Table 128. BOC Sciences Latest Developments
Table 129. TargetMol Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 130. TargetMol Filgotinib Product Portfolios and Specifications
Table 131. TargetMol Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 132. TargetMol Main Business
Table 133. TargetMol Latest Developments
Table 134. Toronto Research Chemicals Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 135. Toronto Research Chemicals Filgotinib Product Portfolios and Specifications
Table 136. Toronto Research Chemicals Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 137. Toronto Research Chemicals Main Business
Table 138. Toronto Research Chemicals Latest Developments
Table 139. J&K Scientific Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 140. J&K Scientific Filgotinib Product Portfolios and Specifications
Table 141. J&K Scientific Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 142. J&K Scientific Main Business
Table 143. J&K Scientific Latest Developments
Table 1. Filgotinib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Filgotinib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Filgotinib Sales by Type (2019-2024) & (Kg)
Table 7. Global Filgotinib Sales Market Share by Type (2019-2024)
Table 8. Global Filgotinib Revenue by Type (2019-2024) & ($ million)
Table 9. Global Filgotinib Revenue Market Share by Type (2019-2024)
Table 10. Global Filgotinib Sale Price by Type (2019-2024) & (K USD/Kg)
Table 11. Global Filgotinib Sales by Application (2019-2024) & (Kg)
Table 12. Global Filgotinib Sales Market Share by Application (2019-2024)
Table 13. Global Filgotinib Revenue by Application (2019-2024)
Table 14. Global Filgotinib Revenue Market Share by Application (2019-2024)
Table 15. Global Filgotinib Sale Price by Application (2019-2024) & (K USD/Kg)
Table 16. Global Filgotinib Sales by Company (2019-2024) & (Kg)
Table 17. Global Filgotinib Sales Market Share by Company (2019-2024)
Table 18. Global Filgotinib Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Filgotinib Revenue Market Share by Company (2019-2024)
Table 20. Global Filgotinib Sale Price by Company (2019-2024) & (K USD/Kg)
Table 21. Key Manufacturers Filgotinib Producing Area Distribution and Sales Area
Table 22. Players Filgotinib Products Offered
Table 23. Filgotinib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Filgotinib Sales by Geographic Region (2019-2024) & (Kg)
Table 27. Global Filgotinib Sales Market Share Geographic Region (2019-2024)
Table 28. Global Filgotinib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Filgotinib Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Filgotinib Sales by Country/Region (2019-2024) & (Kg)
Table 31. Global Filgotinib Sales Market Share by Country/Region (2019-2024)
Table 32. Global Filgotinib Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Filgotinib Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Filgotinib Sales by Country (2019-2024) & (Kg)
Table 35. Americas Filgotinib Sales Market Share by Country (2019-2024)
Table 36. Americas Filgotinib Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Filgotinib Revenue Market Share by Country (2019-2024)
Table 38. Americas Filgotinib Sales by Type (2019-2024) & (Kg)
Table 39. Americas Filgotinib Sales by Application (2019-2024) & (Kg)
Table 40. APAC Filgotinib Sales by Region (2019-2024) & (Kg)
Table 41. APAC Filgotinib Sales Market Share by Region (2019-2024)
Table 42. APAC Filgotinib Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Filgotinib Revenue Market Share by Region (2019-2024)
Table 44. APAC Filgotinib Sales by Type (2019-2024) & (Kg)
Table 45. APAC Filgotinib Sales by Application (2019-2024) & (Kg)
Table 46. Europe Filgotinib Sales by Country (2019-2024) & (Kg)
Table 47. Europe Filgotinib Sales Market Share by Country (2019-2024)
Table 48. Europe Filgotinib Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Filgotinib Revenue Market Share by Country (2019-2024)
Table 50. Europe Filgotinib Sales by Type (2019-2024) & (Kg)
Table 51. Europe Filgotinib Sales by Application (2019-2024) & (Kg)
Table 52. Middle East & Africa Filgotinib Sales by Country (2019-2024) & (Kg)
Table 53. Middle East & Africa Filgotinib Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Filgotinib Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Filgotinib Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Filgotinib Sales by Type (2019-2024) & (Kg)
Table 57. Middle East & Africa Filgotinib Sales by Application (2019-2024) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Filgotinib
Table 59. Key Market Challenges & Risks of Filgotinib
Table 60. Key Industry Trends of Filgotinib
Table 61. Filgotinib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Filgotinib Distributors List
Table 64. Filgotinib Customer List
Table 65. Global Filgotinib Sales Forecast by Region (2025-2030) & (Kg)
Table 66. Global Filgotinib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Filgotinib Sales Forecast by Country (2025-2030) & (Kg)
Table 68. Americas Filgotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Filgotinib Sales Forecast by Region (2025-2030) & (Kg)
Table 70. APAC Filgotinib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Filgotinib Sales Forecast by Country (2025-2030) & (Kg)
Table 72. Europe Filgotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Filgotinib Sales Forecast by Country (2025-2030) & (Kg)
Table 74. Middle East & Africa Filgotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Filgotinib Sales Forecast by Type (2025-2030) & (Kg)
Table 76. Global Filgotinib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Filgotinib Sales Forecast by Application (2025-2030) & (Kg)
Table 78. Global Filgotinib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Cayman Chemical Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 80. Cayman Chemical Filgotinib Product Portfolios and Specifications
Table 81. Cayman Chemical Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 82. Cayman Chemical Main Business
Table 83. Cayman Chemical Latest Developments
Table 84. BioVision Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 85. BioVision Filgotinib Product Portfolios and Specifications
Table 86. BioVision Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 87. BioVision Main Business
Table 88. BioVision Latest Developments
Table 89. Adooq Bioscience Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 90. Adooq Bioscience Filgotinib Product Portfolios and Specifications
Table 91. Adooq Bioscience Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 92. Adooq Bioscience Main Business
Table 93. Adooq Bioscience Latest Developments
Table 94. Taiclone Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 95. Taiclone Filgotinib Product Portfolios and Specifications
Table 96. Taiclone Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 97. Taiclone Main Business
Table 98. Taiclone Latest Developments
Table 99. Clearsynth Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 100. Clearsynth Filgotinib Product Portfolios and Specifications
Table 101. Clearsynth Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 102. Clearsynth Main Business
Table 103. Clearsynth Latest Developments
Table 104. Biorbyt Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 105. Biorbyt Filgotinib Product Portfolios and Specifications
Table 106. Biorbyt Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 107. Biorbyt Main Business
Table 108. Biorbyt Latest Developments
Table 109. APExBIO Technology Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 110. APExBIO Technology Filgotinib Product Portfolios and Specifications
Table 111. APExBIO Technology Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 112. APExBIO Technology Main Business
Table 113. APExBIO Technology Latest Developments
Table 114. Selleck Chemicals Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 115. Selleck Chemicals Filgotinib Product Portfolios and Specifications
Table 116. Selleck Chemicals Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 117. Selleck Chemicals Main Business
Table 118. Selleck Chemicals Latest Developments
Table 119. AbMole Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 120. AbMole Filgotinib Product Portfolios and Specifications
Table 121. AbMole Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 122. AbMole Main Business
Table 123. AbMole Latest Developments
Table 124. BOC Sciences Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 125. BOC Sciences Filgotinib Product Portfolios and Specifications
Table 126. BOC Sciences Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 127. BOC Sciences Main Business
Table 128. BOC Sciences Latest Developments
Table 129. TargetMol Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 130. TargetMol Filgotinib Product Portfolios and Specifications
Table 131. TargetMol Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 132. TargetMol Main Business
Table 133. TargetMol Latest Developments
Table 134. Toronto Research Chemicals Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 135. Toronto Research Chemicals Filgotinib Product Portfolios and Specifications
Table 136. Toronto Research Chemicals Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 137. Toronto Research Chemicals Main Business
Table 138. Toronto Research Chemicals Latest Developments
Table 139. J&K Scientific Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 140. J&K Scientific Filgotinib Product Portfolios and Specifications
Table 141. J&K Scientific Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 142. J&K Scientific Main Business
Table 143. J&K Scientific Latest Developments
LIST OF FIGURES
Figure 1. Picture of Filgotinib
Figure 2. Filgotinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Filgotinib Sales Growth Rate 2019-2030 (Kg)
Figure 7. Global Filgotinib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Filgotinib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Filgotinib Sales Market Share by Type in 2023
Figure 13. Global Filgotinib Revenue Market Share by Type (2019-2024)
Figure 14. Filgotinib Consumed in Research
Figure 15. Global Filgotinib Market: Research (2019-2024) & (Kg)
Figure 16. Filgotinib Consumed in Medical
Figure 17. Global Filgotinib Market: Medical (2019-2024) & (Kg)
Figure 18. Global Filgotinib Sales Market Share by Application (2023)
Figure 19. Global Filgotinib Revenue Market Share by Application in 2023
Figure 20. Filgotinib Sales Market by Company in 2023 (Kg)
Figure 21. Global Filgotinib Sales Market Share by Company in 2023
Figure 22. Filgotinib Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Filgotinib Revenue Market Share by Company in 2023
Figure 24. Global Filgotinib Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Filgotinib Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Filgotinib Sales 2019-2024 (Kg)
Figure 27. Americas Filgotinib Revenue 2019-2024 ($ Millions)
Figure 28. APAC Filgotinib Sales 2019-2024 (Kg)
Figure 29. APAC Filgotinib Revenue 2019-2024 ($ Millions)
Figure 30. Europe Filgotinib Sales 2019-2024 (Kg)
Figure 31. Europe Filgotinib Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Filgotinib Sales 2019-2024 (Kg)
Figure 33. Middle East & Africa Filgotinib Revenue 2019-2024 ($ Millions)
Figure 34. Americas Filgotinib Sales Market Share by Country in 2023
Figure 35. Americas Filgotinib Revenue Market Share by Country in 2023
Figure 36. Americas Filgotinib Sales Market Share by Type (2019-2024)
Figure 37. Americas Filgotinib Sales Market Share by Application (2019-2024)
Figure 38. United States Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Filgotinib Sales Market Share by Region in 2023
Figure 43. APAC Filgotinib Revenue Market Share by Regions in 2023
Figure 44. APAC Filgotinib Sales Market Share by Type (2019-2024)
Figure 45. APAC Filgotinib Sales Market Share by Application (2019-2024)
Figure 46. China Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Filgotinib Sales Market Share by Country in 2023
Figure 54. Europe Filgotinib Revenue Market Share by Country in 2023
Figure 55. Europe Filgotinib Sales Market Share by Type (2019-2024)
Figure 56. Europe Filgotinib Sales Market Share by Application (2019-2024)
Figure 57. Germany Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Filgotinib Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Filgotinib Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Filgotinib Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Filgotinib Sales Market Share by Application (2019-2024)
Figure 66. Egypt Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Filgotinib in 2023
Figure 72. Manufacturing Process Analysis of Filgotinib
Figure 73. Industry Chain Structure of Filgotinib
Figure 74. Channels of Distribution
Figure 75. Global Filgotinib Sales Market Forecast by Region (2025-2030)
Figure 76. Global Filgotinib Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Filgotinib Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Filgotinib Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Filgotinib Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Filgotinib Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Filgotinib
Figure 2. Filgotinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Filgotinib Sales Growth Rate 2019-2030 (Kg)
Figure 7. Global Filgotinib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Filgotinib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Filgotinib Sales Market Share by Type in 2023
Figure 13. Global Filgotinib Revenue Market Share by Type (2019-2024)
Figure 14. Filgotinib Consumed in Research
Figure 15. Global Filgotinib Market: Research (2019-2024) & (Kg)
Figure 16. Filgotinib Consumed in Medical
Figure 17. Global Filgotinib Market: Medical (2019-2024) & (Kg)
Figure 18. Global Filgotinib Sales Market Share by Application (2023)
Figure 19. Global Filgotinib Revenue Market Share by Application in 2023
Figure 20. Filgotinib Sales Market by Company in 2023 (Kg)
Figure 21. Global Filgotinib Sales Market Share by Company in 2023
Figure 22. Filgotinib Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Filgotinib Revenue Market Share by Company in 2023
Figure 24. Global Filgotinib Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Filgotinib Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Filgotinib Sales 2019-2024 (Kg)
Figure 27. Americas Filgotinib Revenue 2019-2024 ($ Millions)
Figure 28. APAC Filgotinib Sales 2019-2024 (Kg)
Figure 29. APAC Filgotinib Revenue 2019-2024 ($ Millions)
Figure 30. Europe Filgotinib Sales 2019-2024 (Kg)
Figure 31. Europe Filgotinib Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Filgotinib Sales 2019-2024 (Kg)
Figure 33. Middle East & Africa Filgotinib Revenue 2019-2024 ($ Millions)
Figure 34. Americas Filgotinib Sales Market Share by Country in 2023
Figure 35. Americas Filgotinib Revenue Market Share by Country in 2023
Figure 36. Americas Filgotinib Sales Market Share by Type (2019-2024)
Figure 37. Americas Filgotinib Sales Market Share by Application (2019-2024)
Figure 38. United States Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Filgotinib Sales Market Share by Region in 2023
Figure 43. APAC Filgotinib Revenue Market Share by Regions in 2023
Figure 44. APAC Filgotinib Sales Market Share by Type (2019-2024)
Figure 45. APAC Filgotinib Sales Market Share by Application (2019-2024)
Figure 46. China Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Filgotinib Sales Market Share by Country in 2023
Figure 54. Europe Filgotinib Revenue Market Share by Country in 2023
Figure 55. Europe Filgotinib Sales Market Share by Type (2019-2024)
Figure 56. Europe Filgotinib Sales Market Share by Application (2019-2024)
Figure 57. Germany Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Filgotinib Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Filgotinib Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Filgotinib Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Filgotinib Sales Market Share by Application (2019-2024)
Figure 66. Egypt Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Filgotinib Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Filgotinib in 2023
Figure 72. Manufacturing Process Analysis of Filgotinib
Figure 73. Industry Chain Structure of Filgotinib
Figure 74. Channels of Distribution
Figure 75. Global Filgotinib Sales Market Forecast by Region (2025-2030)
Figure 76. Global Filgotinib Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Filgotinib Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Filgotinib Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Filgotinib Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Filgotinib Revenue Market Share Forecast by Application (2025-2030)
